Medicamen Biotec

Medicamen_Biotec02 Mar 2024
Pharmaceuticals
-0.20 (-0.04%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Medicamen Biotec
Medicamen Biotec
Pharmaceuticals
Medicamen_Biotec02 Mar 2024
-0.20 (-0.04%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Medicamen Biotec - Share Price & Details

Lowest Today
483
Highest Today
509.4
Today’s Open
500.95
Prev. Close
491.25
52 Week High
903.5
52 Week Low
470.3
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-25.49%
Upper Circuit
Lower Circuit
P/E TTM
43.61
P/B Ratio
3.09
Traded Value(Cr)
0.00
EPS TTM
11.26
Book value
Dividend
0.20%

Price Performance

-3.65 %
1 Wk
-9.29 %
1 M
-22.48 %
3 M
-25.49 %
1 Y
-17.13 %
YTD

Traded Volume Movement

Technical Details

Support 3
460
Support 2
473
Support 1
482
Pivot Point :
495
Resistance 1
504
Resistance 2
517
Resistance 3
526

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Medicamen Biotech Ltd
₹491.05(-0.20/-0.04%)
491.05-0.20621.23-25.4943.613.09
Cipla Ltd
₹1,483.10(+12.50/0.85%)
1,483.10+12.50119,739.4963.4336.414.63
Astrazeneca Pharma India Ltd
₹5,439.40(-9.95/-0.18%)
5,439.40-9.9513,598.5061.7485.2620.76
Bliss GVS Pharma Ltd
₹125.90(+0.85/0.68%)
125.90+0.851,318.0659.0819.311.35
Abbott India Ltd
₹28,079.40(-135.60/-0.48%)
28,079.40-135.6059,668.7340.6652.0919.19
Amrutanjan Health Care Ltd
₹669.35(+3.15/0.47%)
669.35+3.151,956.556.8144.457.47

About Medicamen Biotech Ltd

Medicamen Biotech Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 621.23 crores. It has reported a sales of Rs. 44.2 crores and a net profit of Rs. 2.77 crores for the quarter ended December 2018. The company management includes Rahul Bishnoi, Sanjay Bansal,Rahul Bishnoi,Ashwani Kumar Sharma,Harish Pande,S K Singh,Arun Kumar,Parul Choudhary,Sumita Dwivedi,Vimal Kumar Shrawat.,Sangeeta Bishnoi,Ravi Kumar Bansal (Medicamen Biotech Ltd) among others.
Chairman
Rahul Bishnoi
Registered office
1506 Chiranjiv Tower 43,Nehru Place,New Delhi,New Delhi,110019
FAX :91-11-26213081
Background
Incorporation Year1993
Face Value₹10
Market Lot1

Latest News

Mcap of 7 of top 10 most valued firms climb Rs 65,302 cr
The combined market valuation of seven of the top 10 most valued firms climbed Rs 65,302.5 crore last week, with TCS and ICICI Bank emerging as the biggest gainers. Last week, the BSE benchmark Sensex climbed 663.35 points or 0.90%, and the Nifty jumped 165.7 points or 0.74%. BSE and NSE conducted a special trading session in the equity and equity derivative segments on Saturday.
03 Mar 2024 | 11:21 AM
FPIs reverse trend; infuse Rs 1,500 crore into Indian equities in February
Foreign investors made a significant turnaround and injected over Rs 1,500 crore into Indian equities in February, reversing the massive outflows seen in the preceding month, primarily due to robust corporate earnings and positive economic growth. Additionally, Foreign Portfolio Investors (FPIs) continued to be bullish on the debt markets.
03 Mar 2024 | 11:10 AM
PM flags off 1st crude oil tanker from ONGC's KG project
Prime Minister Narendra Modi on Saturday flagged off tanker 'Swarna Sindhu', carrying the first parcel of crude oil from ONGC's recently commissioned Krishna Godavari deepwater project. At its peak production, this project will add 7 per cent each to India's oil and gas production, Oil and Natural Gas Corporation (ONGC) said in a statement.
03 Mar 2024 | 11:08 AM
Mcap of 7 of top 10 most valued firms climb Rs 65,302 cr
The combined market valuation of seven of the top 10 most valued firms climbed Rs 65,302.5 crore last week, with TCS and ICICI Bank emerging as the biggest gainers. Last week, the BSE benchmark Sensex climbed 663.35 points or 0.90%, and the Nifty jumped 165.7 points or 0.74%. BSE and NSE conducted a special trading session in the equity and equity derivative segments on Saturday.
03 Mar 2024 | 11:21 AM
FPIs reverse trend; infuse Rs 1,500 crore into Indian equities in February
Foreign investors made a significant turnaround and injected over Rs 1,500 crore into Indian equities in February, reversing the massive outflows seen in the preceding month, primarily due to robust corporate earnings and positive economic growth. Additionally, Foreign Portfolio Investors (FPIs) continued to be bullish on the debt markets.
03 Mar 2024 | 11:10 AM
Click here to see your activities